NCT05893654 2025-09-15
MELCOM
Hospital das ClÃnicas de Ribeirão Preto
Phase 1/2 Enrolling by invitation
Clinical Trials
3 trialsNCT01531244 2014-07-18
Isolated Limb Infusion Chemotherapy With Targeted Gene Therapy for Advanced, Unresectable Extremity Melanoma
Washington University School of Medicine
Phase 1/2 Withdrawn
NCT00421811 2010-12-28
A Study of ADH-1 in Combination With Normothermic Isolated Limb Infusion of Melphalan
Adherex Technologies, Inc.
Phase 1/2 Completed